618
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective

ORCID Icon, , , , , , , , , , , , , , , , & show all
Article: 2375081 | Received 19 Feb 2024, Accepted 28 Jun 2024, Published online: 09 Jul 2024

References

  • Rodrigues CMC, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020;11. doi:10.3389/FMICB.2020.01526.
  • Lubanga AF, Bwanali AN, Munthali L, Mphepo M, Chumbi GD, Kangoma M, Khuluza C. Malawi vaccination drive: an integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges. Hum Vaccin Immunother. 2023;19(2). doi:10.1080/21645515.2023.2233397.
  • Immunization | WHO | Regional Office for Africa. https://www.afro.who.int/health-topics/immunization.
  • Sheahan KL, Speizer I, Curtis S, Weinberger M, Paul J, Bennett AV. Influence of family planning and immunization services integration on contraceptive use and family planning information and knowledge among clients: a cross-sectional analysis in urban Nigeria. Front Glob Womens Health. 2022;3. doi:10.3389/fgwh.2022.859832.
  • Huntington D, Aplogan A. The integration of family planning and childhood immunization services in Togo. Stud Fam Plann. 1994;25(3):176. doi:10.2307/2137943.
  • Nelson AR, Cooper CM, Kamara S, Taylor ND, Zikeh T, Kanneh-Kesselly C, Fields R, Hossain I, Oseni L, Getahun BS, et al. Operationalizing integrated immunization and family planning services in rural Liberia: lessons learned from evaluating service quality and utilization. Glob Health Sci Pract. 2019;7(3):418–114. doi:10.9745/GHSP-D-19-00012.
  • Sheahan KL, Orgill-Meyer J, Speizer IS, Curtis S, Paul J, Weinberger M, Bennett AV. Development of integration indexes to determine the extent of family planning and child immunization services integration in health facilities in urban areas of Nigeria. Reprod Health. 2021;18(1). doi:10.1186/s12978-021-01105-y.
  • Sheahan KL, Speizer IS, Orgill-Meyer J, Curtis S, Weinberger M, Paul J, Bennett AV. Facility-level characteristics associated with family planning and child immunization services integration in urban areas of Nigeria: a longitudinal analysis. BMC Public Health. 2021;21(1). doi:10.1186/s12889-021-11436-x.
  • Greenwood B. The contribution of vaccination to global health: past, present and future. Phil Trans R Soc B. 2014;369(1645):20130433. doi:10.1098/RSTB.2013.0433.
  • A database of local vaccine manufacturing commitments and tech-transfers - Clinton health access initiative. https://www.clintonhealthaccess.org/database/a-database-of-local-vaccine-manufacturing-commitments-and-tech-transfers/.
  • Gray A, Sharara F. Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis. Lancet Glob Health. 2022;10:S2. doi:10.1016/s2214-109x(22)00131-0.
  • Azevedo MJ. The state of health system(s) in Africa: challenges and opportunities. Afr Histories Modernities. 2017; 1–73. doi:10.1007/978-3-319-32564-4_1.
  • Feldman AG, O’Leary ST, Danziger-Isakov L. The risk of resurgence in vaccine-preventable infections due to coronavirus disease 2019—related gaps in immunization. Clin Infect Dis. 2021;73(10):1920–3. doi:10.1093/CID/CIAB127.
  • Dabbagh A, Laws RL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, Alexander JP, Rota PA, Goodson JL. Progress toward regional measles elimination — worldwide, 2000–2017. MMWR Morb Mortal Wkly Rep. 2019;67(47):1323–9. doi:10.15585/MMWR.MM6747A6.
  • Masresha BG, Hatcher C, Lebo E, Tanifum P, Bwaka AM, Minta AA, Antoni S, Grant GB, Perry RT, O’Connor P. Progress toward measles elimination — African Region, 2017–2021. MMWR Morb Mortal Wkly Rep. 2023;72(36):985–91. doi:10.15585/mmwr.mm7236a3.
  • Machingaidze S, Wiysonge CS, Hussey GD. Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLOS Med. 2013;10(3):e1001405. doi:10.1371/journal.pmed.1001405.
  • Uwizihiwe JP. 40th anniversary of introduction of Expanded Immunization Program (EPI): a literature review of introduction of new vaccines for routine childhood immunization in Sub-Saharan Africa. Int J Vaccines & Vaccination. 2015;1(1). doi:10.15406/ijvv.2015.01.00004.
  • Dixon MG, Ferrari MAS, Antoni S, Li X, Portnoy A, Lambert B, Hauryski S, Hatcher C, Nedelec Y, Patel M, et al. Progress toward regional measles elimination — worldwide, 2000 – 2020. MMWR Morb Mortal Wkly Rep. 2020;70(45):1563–9. doi:10.15585/mmwr.mm7045a1.
  • Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele J-M, Dumolard L, Rota PA, Kretsinger K, Goodson JL. Morbidity and mortality weekly report progress toward regional measles elimination-worldwide, 2000-2015. 2016.
  • Measles – Africa CDC. https://africacdc.org/disease/measles/.
  • Focus Lubanga A, Bwanali N, Munthali L, Mphepo M, Chumbi GD, Kangoma M, Khuluza C. Malawi vaccination drive: an integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges. Hum Vaccines Immunother. 2023;19(2). doi:10.1080/21645515.2023.2233397.
  • WHO: WHO | Poliomyelitis. WHO; 2020.
  • Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
  • Fast facts on global immunization. https://www.cdc.gov/globalhealth/immunization/data/fast-facts.html.
  • Frenkel LD. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? Allergy Asthma Proc. 2021;42(5):378–85. doi:10.2500/AAP.2021.42.210065.
  • Strategic Advisory Group of Experts on Immunization. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers.
  • Masresha BG, Hatcher C, Lebo E, Tanifum P, Bwaka AM, Minta AA, Antoni S, Grant GB, Perry RT, O’Connor P. Progress toward measles elimination — African Region, 2017–2021. MMWR Morb Mortal Wkly Rep. 2023;72(36):985–91. doi:10.15585/MMWR.MM7236A3.
  • Malawi – GPEI. https://polioeradication.org/where-we-work/malawi/.
  • Masresha B, Shibeshi M, Kaiser R, Luce R, Katsande R, Mihigo R. Congenital Rubella syndrome in the African region - data from sentinel surveillance. J Immunol Sci Suppl. 2018;2(SI1):145–9. doi:10.29245/2578-3009/2018/si.1122.
  • Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Kassianides C, Kew M, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900. doi:10.1016/S2468-1253(17)30295-9.
  • Clarke KEN, MacNeil A, Hadler S, Scott C, Tiwari TSP, Cherian T. Global epidemiology of Diphtheria, 2000–2017. Emerg Infect Dis. 2019;25(10):1834. doi:10.3201/EID2510.190271.
  • Diphtheria-Nigeria. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON452.
  • WHO. WHO and UNICEF warn of a decline in vaccinations during COVID-19. Geneva: World Health organization; 2020.
  • Greenlee CJ, Newton SS. A review of traditional vaccine-preventable diseases and the potential impact on the otolaryngologist. Int Arch Otorhinolaryngol. 2018;22(03):317–29. doi:10.1055/S-0037-1604055.
  • Weak Vaccine-Preventable Disease Surveillance Could Cost the African Region $22.4 billion over the next decade, WHO Warns - World | ReliefWeb. https://reliefweb.int/report/world/weak-vaccine-preventable-disease-surveillance-could-cost-african-region-224-billion.
  • IJERPH | Special Issue : Re-Emergence of Vaccine-Preventable Diseases. https://www.mdpi.com/journal/ijerph/special_issues/REVPD.
  • Ogundele OA, Omotoso AA, Fagbemi AT. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria. Hum Vaccines Immunotherapeutics. 2021;17(3):661–3. doi:10.1080/21645515.2020.1815490.
  • Chukwu OA, Kapiriri L, Essue B. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria. Int J Pharm Pract. 2022;30(3):284–7. doi:10.1093/ijpp/riac028.
  • Hungerford D, Cunliffe NA. Coronavirus disease (COVID-19) – impact on vaccine preventable diseases. Eurosurveillance. 2020;25(18). doi:10.2807/1560-7917.ES.2020.25.18.2000756.
  • Nchasi G, Paul IK, Sospeter SB, Mallya MR, Ruaichi J, Malunga J. Measles outbreak in sub-Saharan Africa amidst COVID-19: a rising concern, efforts, challenges, and future recommendations. Ann Med Surg (Lond). 2022;81. doi:10.1016/J.AMSU.2022.104264.
  • Bangura JB, Xiao S, Qiu D, Ouyang F, Chen L. Barriers to childhood immunization in sub-Saharan Africa: a systematic review. BMC Public Health. 2020;20(1). doi:10.1186/S12889-020-09169-4.
  • Uthman OA, Sambala EZ, Adamu AA, Ndwandwe D, Wiyeh AB, Olukade T, Bishwajit G, Yaya S, Okwo-Bele JM, Wiysonge CS. Does it really matter where you live? A multilevel analysis of factors associated with missed opportunities for vaccination in sub-Saharan Africa. Hum Vaccin Immunother. 2018;14(10):2397. doi:10.1080/21645515.2018.1504524.
  • Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi MP, Stuart JM. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data. Lancet Infect Dis. 2017;17(8):867–72. doi:10.1016/S1473-3099(17)30301-8.
  • Mallory ML, Lindesmith LC, Baric RS. Vaccination-induced herd immunity: Successes and challenges. J Allergy Clin Immunol. 2018;142(1):64–6. doi:10.1016/J.JACI.2018.05.007.
  • De Cellès MD, Riolo MA, Magpantay FMG, Rohani P, King AA. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci USA. 2014;111(7). doi:10.1073/PNAS.1323795111.
  • Progress reports. https://www.gavi.org/programmes-impact/our-impact/progress-reports.
  • Focus Lubanga A, Bwanali N, Kambiri F, Harawa G, Mudenda S, Mpinganjira SL, Singano N, Makole T, Kapatsa T, Kamayani M, et al. Expert review of anti-infective therapy tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines. Expert Rev Anti-Infect Ther. 2024; doi:10.1080/14787210.2024.2362270.
  • Bigdeli M, Peters DH, Wagner AK. Medicines in health systems: advancing access, affordability and appropriate use. Columbia: Columbia University Libraries; 2014.
  • Ewuoso C. What COVID-19 vaccine distribution disparity reveals about solidarity. Vaccine Distribution Disparity Solidarity, Voices In Bioethics. 2024;10. doi:10.52214/vib.v10i.12042.
  • Niohuru I. Healthcare and Disease Burden in Africa. England: Springer; 2023.
  • Shimizu K, Checchi F, Warsame A. Disparities in health financing allocation among infectious diseases in Ebola Virus Disease (EVD)-affected countries, 2005–2017. Healthcare (Basel). 2022;10(2):179. doi:10.3390/HEALTHCARE10020179.
  • Domo NR, Nuolabong C, Nyarko KM, Kenu E, Balagumyetime P, Konnyebal G, Noora CL, Ameme KD, Wurapa F, Afari E. Uncommon mixed outbreak of pneumococcal and meningococcal meningitis in Jirapa District, Upper West Region, Ghana, 2016. Ghana Med J. 2017;51(4):149. doi:10.4314/gmj.v51i4.2.
  • Gautret P, Botelho-Nevers E, Brouqui P, Parola P. The spread of vaccine-preventable diseases by international travellers: a public-health concern. Clin Microbiol Infect. 2012;18(Suppl 5):77–84. doi:10.1111/J.1469-0691.2012.03940.X.
  • Makenga G, Bonoli S, Montomoli E, Carrier T, Auerbach J. Vaccine production in Africa: a feasible business model for capacity building and sustainable new vaccine introduction. Front Public Health. 2019;7. doi:10.3389/FPUBH.2019.00056.
  • Ali I, Hamid S. Implications of COVID-19 and “super floods” for routine vaccination in Pakistan: the reemergence of vaccine preventable-diseases such as polio and measles. Hum Vaccin Immunother. 2022;18(7). doi:10.1080/21645515.2022.2154099.
  • Sodjinou VD, Mengouo MN, Douba A, Tanifum P, Yapi MD, Kuzanwa KR, Otomba JS, Masresha B. Epidemiological characteristics of a protracted and widespread measles outbreak in the Democratic Republic of Congo, 2018-2020. Pan Afr Med J. 2022;42. doi:10.11604/pamj.2022.42.282.34410.
  • United Nations Office for the Coordination of Humanitarian Affairs (OCHA). The impact of violence against health care on the health of children and mothers acase study in three health zones in eastern DRC 2. 2024.
  • Kayembe HC, Bompangue D, Linard C, Mandja BA, Batumbo D, Matunga M, Muwonga J, Moutschen M, Situakibanza H, Ozer P, et al. Drivers of the dynamics of the spread of cholera in the Democratic Republic of the Congo, 2000–2018: an eco-epidemiological study. PloS Negl Trop Dis. 2023;17(8):e0011597. doi:10.1371/journal.pntd.0011597.
  • Roberts L. Why measles deaths are surging — and coronavirus could make it worse. Nature. 2020;580(7804):446–7. doi:10.1038/d41586-020-01011-6.
  • Mbaeyi C, Moran T, Wadood Z, Ather F, Sykes E, Nikulin J, Al Safadi M, Stehling-Ariza T, Zomahoun L, Ismaili A, et al. Stopping a polio outbreak in the midst of war: lessons from Syria. Vaccine. 2021;39(28):3717–23. doi:10.1016/J.VACCINE.2021.05.045.
  • Focus Adriano L, Nazir A, Uwishema O. The devastating effect of cyclone Freddy amidst the deadliest cholera outbreak in Malawi: a double burden for an already weak healthcare system—short communication. Ann Of Med & Surg. 2023;85(7):3761–3. doi:10.1097/ms9.0000000000000961.
  • Lubanga AF, Bwanali AN, Munthali L, Chumbi GD, Mphepo M. What should be Malawi’s goal in cholera control and prevention? Lessons from the deadliest cholera outbreak in two decades. Int J Surg: Global Health. 2023;6(5). doi:10.1097/gh9.0000000000000300.
  • Roberts L. Africa battles out-of-control polio outbreaks. Science. 2022;375(6585):1079–80. doi:10.1126/SCIENCE.ADB1920.
  • Guglielmi G. Africa declared free from wild polio - but vaccine-derived strains remain. Nature. 2020; doi:10.1038/D41586-020-02501-3.
  • Health equity. https://www.who.int/health-topics/health-equity#tab=tab_1.
  • Shim RS, Compton MT. Addressing the social determinants of mental health: if not now, when? If not us, who? Psychiatr Serv. 2018;69(8):844–6. doi:10.1176/appi.ps.201800060.
  • Rodriguez D. WHO | About Social Determinants Of Health. Geneva: World Health organization; 2017.
  • Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet. 2012;380(9846):1011–29. doi:10.1016/S0140-6736(12)61228-8.
  • Azevedo MJ. Historical perspectives on the state of health and health systems in Africa. Vol. II. 2017. doi:10.1007/978-3-319-32564-4.
  • Osewe PL, Peters MA. Prioritizing global public health investments for COVID-19 response in real time: results from a delphi exercise. Health Secur. 2022;20(2):137–46. doi:10.1089/hs.2021.0142.
  • Kutzin J, Witter S, Jowett M, Bayarsaikhan D. Developing a national health financing strategy: a reference guide. Geneva: World Health Organization; 2017.
  • Tandon A, Reddy KS. Redistribution and the health financing transition. J Glob Health. 2021;11:16002. doi:10.7189/JOGH.11.16001.
  • Spicer N, Agyepong I, Ottersen T, Jahn A, Ooms G. ‘It’s far too complicated’: why fragmentation persists in global health. Global Health. 2020;16(1). doi:10.1186/S12992-020-00592-1.
  • Wariri O, Edem B, Nkereuwem E, Nkereuwem OO, Umeh G, Clark E, Idoko OT, Nomhwange T, Kampmann B. Tracking coverage, dropout and multidimensional equity gaps in immunisation systems in West Africa, 2000–2017. BMJ Glob Health. 2019;4(5):e001713. doi:10.1136/bmjgh-2019-001713.
  • WHO EMRO | Historic commitment from African Heads of State to advance immunization in Africa | News | Media centre. https://www.emro.who.int/media/news/historic-commitment-from-african-heads-of-state-to-advance-immunization-in-africa.html.
  • Investment case for vaccine-preventable diseases surveillance in the African Region. 2019.
  • The greater Horn of Africa’s climate-related health crisis worsens as disease outbreaks surge | WHO | Regional Office for Africa. https://www.afro.who.int/news/greater-horn-africas-climate-related-health-crisis-worsens-disease-outbreaks-surge.
  • Focus Adriano L, Nazir A, Uwishema O. The devastating effect of cyclone Freddy amidst the deadliest cholera outbreak in Malawi: a double burden for an already weak healthcare system—short communication. Ann Med Surg (Lond). 2023;85(7):3761–3. doi:10.1097/MS9.0000000000000961.
  • COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades. https://www.who.int/news/item/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades.
  • Borba RCN, Vidal VM, Moreira LDO. The re-emergency and persistence of vaccine preventable diseases. An Acad Bras Ciênc. 2015;87(2 suppl):1311–22. doi:10.1590/0001-3765201520140663.
  • Current and planned vaccine manufacturing in Africa - Clinton health access initiative. https://www.clintonhealthaccess.org/report/current-and-planned-vaccine-manufacturing-in-africa/.
  • Oduoye MO, Zuhair V, Marbell A, Olatunji GD, Khan AA, Farooq A, Jamiu AT, Karim KA. The recent measles outbreak in South African Region is due to low vaccination coverage. What should we do to mitigate it? New Microbes New Infect. 2023;54:101164. doi:10.1016/J.NMNI.2023.101164.
  • Basu S, Ashok G, Debroy R, Ramaiah S, Livingstone P, Anbarasu A. Impact of the COVID-19 pandemic on routine vaccine landscape: a global perspective. Hum Vaccin Immunother. 2023;19(1). doi:10.1080/21645515.2023.2199656.
  • Scaling Up African vaccine manufacturing capacity perspectives from the African vaccine-manufacturing industry on the challenges and the need for support. 2023.
  • Saied AA, Metwally AA, Dhawan M, Choudhary OP, Aiash H. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. EMBO Mol Med. 2022;14(8). doi:10.15252/emmm.202216287.
  • Souliotis K, Grima S, Makenga G, Bonoli S, Montomoli E, Carrier T, Auerbach J. Vaccine production in Africa: a feasible business model for capacity building and sustainable new vaccine introduction. Front Public Health. 2019;7:56. doi:10.3389/fpubh.2019.00056.
  • Kumraj G, Pathak S, Shah S, Majumder P, Jain J, Bhati D, Hanif S, Mukherjee S, Ahmed S. Capacity building for vaccine manufacturing across developing countries: the way forward. Hum Vaccin Immunother. 2022;18(1). doi:10.1080/21645515.2021.2020529.
  • John-Joy Owolade A, Oluwaseun Sokunbi T, Oluwatobi Aremu F, Oluwatosin Omotosho E, Abai Sunday B, Adebayo Adebisi Y, Ekpenyong A, Opeyemi Babatunde A. Strengthening Africa’s capacity for vaccine research: needs and challenges. Tabriz Univ Of Med Sci. 2022;12(3):282–285. doi:10.34172/hpp.2022.36.
  • Akegbe H, Onyeaka H, Michael Mazi I, Alex Olowolafe O, Dolapo Omotosho A, Olatunji Oladunjoye I, Amuda Tajudeen Y, Seun Ofeh A. The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance. Vaccine: X. 2023;14:100320. doi:10.1016/j.jvacx.2023.100320.